Send to

Choose Destination
Circulation. 2014 Aug 26;130(9):e85. doi: 10.1161/CIRCULATIONAHA.114.010275.

Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study".

Author information

European Georges Pompidou Hospital and Paris Descartes University, Paris, France.
Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
Boehringer Ingelheim Pharma GmbH & Co KG, Clinical Development and Medical Affairs, Ingelheim am Rhein, Germany, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany.
Cardiovascular Research Foundation and Thomas Jefferson Medical College, New York, NY.
Uppsala Clinical Research Centre, University Hospital, Uppsala, Sweden.
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center